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The distribution, excretion and biotransformation of 14C-cloxazolam were studied in rats and mice. The tissue concentration reached the maximum at about 1 and 3 hr after oral administration to rats and mice, respectively. The brain concentration was higher and lasted longer in mice than in rats.
In the whole-body autoradiograms of mice, no significant radioactivity was detected in the tissues except the liver after 24 hr and the radioactivity disappeared almost completely after 72 hr. The recovery of radioactivity was considerably higher in the feces than in the urine and was about the same regardless of the route of administration in both rats and mice. In the in situ cannulated rats, the most of the oral dose was recovered in the bile in 24 hr period.
Eighteen radioactive metabolites were detected in the liver, urine and feces after oral administration of 14C-cloxazolam.
Among them, eight metabolites including 7-chloro-2,3-dihydro-5-[o-chlorophenyl]-2H-1,4-benzodiazepin-2-one, 7-chloro-5-[o-chlorophenyl]-1, 3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (COX) and 2-amino-3-hydroxy-2',5-dichlorobenzophenone (ADCB-OH) were isolated and identified.
The main metabolites in the mouse urine were the glucuronides of COX and ADCB-OH, while in the rat urine two unidentified metabolites in addition to the above two. In the mouse feces, COX and ADCB-OH and their conjugates were the main metabolites, while in the rat feces a much larger number of metabolites were detected.
Cloxazolam, newly synthesized in our laboratories, is 10-chloro-2, 3,5,6,7,11b-hexahydro11b-[o-chlorophenyl] It is an analogue of oxazolam, of which the metabolic fate has been already reported,3-5) and has been shown to be much more potent than oxazolam, as an anticonvulsant, muscle relaxant and taming agent in animals.6) In addition, it has been reported to be clinically effective against schizophrenia, depression, epileptic psychopathia and neurosis.7)
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(Tokyo), 19, 60 (1971) . 4) A. Yasumura, H. Murata, K. Hattori, and K. Matsuda, Chem. Pharm. Bull. (Tokyo), 19, 1929 (1971 . 5) H. Shindo, T. Komai, K. Tanaka, and K. Kawai, Chem. Pharm. Bull. (Tokyo), 19, 2085 (1971 . 6) T. Kamioka, H. Takagi, S. Kobayashi, and Y. Suzuki, Arzneim.-Forsch., 22, 884 (1972) . 7) T. Maeda, Medical Consultation and New Remedies, 8, 1498 (1971 , 27, 3788 (1962) . 10) S.C. Bell and S. J. Childress, J. Org. Chem., 27, 1691 Chem., 27, (1962 . 11) J.L. Bollman, J.C. Cain, and J.H. Grindlay, J. Lab. Clin. Med., 33, 1349 Med., 33, (1948 . B, L and M. Glucuronic acid on the plate was detected by alkaline silver nitrate reagent and benzidine reagent.12) Radioactivity Measurement All the extracts, solution, suspension, urine and bile were counted in a Beckman LS-250 liquid scintillation spectrometer using toluene-ethanol scintillator consisted of 8 g PPO, 200 mg dimethylPOPOP, 500 ml of toluene and ethanol and 40 g Cab-O-Sil. The radioactivity of the spots on thin-layer chromatogram was estimated by suspending the silica gel powder front the spot in 0.5 or 1.0 ml of water and 15 ml of dioxane-toluene scintillator consisted of 8 g PPO, 200 mg dimethyl POPOP, 800 ml dioxane, 200 ml toluene and 40 g Spectral Measurement-The mass spectra were obtained by JEOL JMA-OISG Mass Spectrometer and the nuclear magnetic resonance (NMR) spectra by Varian HA-100
Spectrometer in deutero-dimethylsulfoxide solution with tetramethylsilane as an internal standard.
Result and Discussion
Whole-body Autoradiography in Mice
Representative autoradiograms from mice 1, 3, 6 and 24 hr after oral administration of 14C-cloxazolam are shown in Fig . 1 . At 1 hr after administration ( Fig. 1-A) , a considerable distribution of radioactivity was observed throughout the body. The highest radioactivity was observed in the stomach and the upper part of small intestine, suggesting an existence of the drug unabsorbed. A high radioactivity was shown in the liver, renal cortex and brown fat, followed by the heart muscle, salivary gland, pancreas and renal medulla. A significant radioactivity was found in the brain, spinal cord and skeletal muscle, while the blood concentration was relatively low. These results indicate that the drug is rapidly taken up by the tissues. A high radioactivity was also seen in the gall bladder, indicating an occurrence of the biliary excretion.
At 3 hr after administration ( Fig. 1-B) , the tissue concentrations of radioactivity became slightly higher than those at 1 hr. A high radioactivity was observed in the gall and urinary bladders and the intestinal contents, indicating a prominent excretion of the drug through the bile as well as the urine. The lachrymal gland and nasal mucosa also showed a high radioactivity. In the central nervous system, the cerebrum, cerebellum and spinal cord showed an appreciable uptake. It was noted that a slightly higher concentration appears to be persisted in the white matter and that a prominent concentration was seen in the trigeminal nerve.
At 0 hr after administration ( Fig. 1-C) , the highest radioactivity was shown in the gall bladder and intestinal contents, indicating that the excretion of the drug through the bile 1958. 407 is highly participating. The concentration in the liver was still high, while that in the muscular tissues and subcutaneous fat decreased to a low level. The concentration in the brain also decreased, but it was noted that an appreciable concentration was still retained in the white matter of the cerebrum, brain stem, trigeminal nerve and pituitary.
At 24 hr after administration ( Fig. 1-D) , some radioactivity was observed only in the intestinal contents and gall bladder and a very low concentration in the liver. At 72 hr, no appreciable radioactivity was observed throughout the body, except the liver which showed a trace of radioactivity.
Distribution and Excretion in Rats and Mice
The concentration of radioactivity in rat tissues after oral administration of 14C-cloxazolam is presented in Table I . At 30 min after administration, the radioactivity was already distributed in various tissues, such as the liver, kidney, brain and muscle. The concentration in the liver was very high and was about 25 times of the blood concentration, followed by the kidney (5 times). The concentration in the brain was slightly lower than that in the blood. The blood and tissue concentrations appear to reach their maxima at about 1 hr after administration and thereafter decreased gradually. After 24 hr, no significant radioactivity was detected in all the tissues except the liver, kidney and skeletal muscle and after 48 hr a very low level only in the liver and kidney.
The concentration of radioactivity in mouse tissues after oral administration of 14C-cloxazolam is shown in Table II . Like rats, the liver concentration was very high and about 17 times of the blood concentration at 30 min after administration.
Unlike rats, on the other hand, the brain concentration was about 2 times higher than that in the blood for the period from 30 min to 7 hr. The concentration in the brain appears to reach the maximum at around 4 hr and the blood and tissue concentrations in mice appear to last longer than those in rats. After 48 hr, however, the tissue concentrations fell off to a very low level. These results are well consistent with those observed by autoradiography. The excretion of radioactivity in rats after oral and intravenous administration of 14C-cloxazolam is shown in Table III . After oral administration, about 13 and 65% of the dose were recovered in the urine and feces, respectively, in 48 hr period, while after intravenous administration about 20 and 58%, respectively, indicating a significant secretion of radioactivity into the intestinal tract, most probably through the biliary excretion. In a separate experiment with cannulated rats, it was found that during 24 hr after oral administration about 91% of the dose was recovered in the bile (Table IV ), indicating that cloxazolam and/or its metabolites are excreted considerably through the bile. It seems probable, therefore, that Each value represnts the mean of 2 animals. a) tissue+contents a considerable fecal excretion observed after oral administration was mostly derived from the absorbed radioactivity which was brought back into the intestinal tract through the biliary excretion. In mice, during 48 hr after oral and intravenous administration, about 40 and 35% of the dose were excreted in the urine and about 46 and 56% in the feces, respectively (Table V) . Thus, the fact that both in rats and mice the urinary excretion of radioactivity was almost the same regardless of the route of administration suggest that cloxazolam is well absorbed from the gastrointestinal tract. This is in consistent with the fact that no detectable amount of unchanged drug was found in the feces of rats and mice after oral administration of 14C-cloxazolam, but a number of metabolites are excreted (Table VII, VIII) .
Isolation and Identification of Metabolites
The urine, bile and fecal and liver extracts from the rats administered with 14C-cloxazolam were subjected to two-dimentional TLC. As shown in Fig. 2 , the largest number of radioactive metabolites (eighteen metabolites, spot 1-18) including cloxazolam (spot 9) were detected in the liver and all of the metabolites found in the urine, feces and bile corresponded to those found in the liver. By the same way, a number of metabolites were detected in the urine and fecal and liver extracts from mice, all of which corresponded to those found in rats, except that spot 0 and 18 were not detected. Among these metabolites, eight compounds were isolated and identified as follows. Spot 4 (CND) -The ethylacetate extracts from the rat liver 1 hr after administration. of 14C-cloxazolam were concentrated in vacuo after drying over Na2SO4, followed by subjecting to TLC with solvent A. The spot 4 (Rf 0.48) was scraped off and eluted with ethanol. The eluate was concentrated and rechromatographed with the same solvent for further purification. The Rf value of the purified sample agreed well with that of authentic CND with solvent A, B, H and I. This was methylated by methyliodide in the presence of sodium methoxide, followed by subjecting to TLC with solvent A, J and K. The product showed the same Rf value as that of authentic CD in all the solvents. The identity was further confirmed by the reverse isotope dilution method. An appropriate amount of non-radioactive CD was added to a certain amount of the methylated product and dissolved in ethanol by heating. After cooling, the precipitated crystals were recrystallized from ethanol 4 times. The specific activity determined after each recrystallization gave a constant value (Table VI) . and the fragment peaks at m/e 155 and 126, corresponding to a compound incorporated with one hydroxyl group into the chlorophenyl ring of ADCB. Therefore, the structure of spot 6 was assigned as CND-OH (Chart 1). The position of hydroxyl group has not been determined. The NMR spectrum showed two doublets ( J=2.4 cps) at 3.17 and 3.58 r corresponding to two aromatic protons and the coupling constant is consistent with that due to aromatic protons at meta positions. Therefore, the hydroxyl group is necessarily located at the position ortho to the amino group. From these findings, the structure of spot 2 was assigned as 2-amino-3-hydroxy-5,2'-dichlorobenzophenone (ADCB-OH). 
Excretion of Metabolites in Urine and Feces
The amount of metabolites excreted in the urine and feces of rats and mice following oral administration of 14C-cloxazolam are shown in Table VII and VIII. In the mouse urine, conjugated COX and ADCB-OH were the main metabolites, which accounted for about 35 and 25% of the urinary excretion of radioactivity, respectively. In the rat urine, on the other hand, spot 11 and 16 were excreted in relatively a large amount, which accounted for about 13 and 12% of the excretion of radioactivity, respectively, in addition to the above two metabolites which accounted for about 16 and 13%, respectively.
In the mouse feces, COX and ADCB-OH including their conjugates were the main metabolites, which accounted for about 23 and 21% of the fecal excretion of radioactivity, respectively. On the other hand, in the rat feces, a much larger number of metabolites than that in mice were detected and among them ADCB-OH was the largest in amount, while COX was comparatively small. These results suggest that there might be some difference in the metabolic pattern of cloxazolam between rats and mice. In mice CND formed from cloxazolam appears to be transformed mainly to COX, which is conjugated further. On the other hand, the metabolism of CND in rats appears to be more complicated than that in mice. 
Metabolic Pathway of Cloxazolam
In the light of metabolites so far identified, a possible metabolic pathway of cloxazolam. is shown in Chart 1. In fact, ADCB (spot 1) and ADCB-OH (spot 2) and its glucuronide 13) H. Murata, K. Kougo, A. Yasumura, and H. Shindo, Chem. Pharm. Bull. (Tokyo), to be published.
(spot 13) were detected on the chromatogram of rat liver extracts after administration of HEAB. ADCB-OH and its glucuronide, as well as three unknown metabolites, were detected in the rat liver extracts after administration of 14C-ADCB (Fig. 4) . Oral Administration of 14C-ADCB As already described, CND-OH (spot (3) and COX (spot 7) and its glucuronide (spot 15), as well as spot 8, 11, 16, 17 and 18 were detected in the liver extracts of rats administered with 14C-CND (Fig. 3) . It was found, furthermore, that spot 8, 11, 16, and 17 are also detected in the rat urine after oral administration of 14C-COX and that the relative intensity of these spots appears to be very similar to that observed after administration of 14C-CND (Fig. 5) . These facts suggest that spot 8, 11, 16, and 17 are all the metabolites derived from COX which was formed from CND. Recently, Schilling, et al.14) reported that lorazepam, same as COX, was transformed to four metabolites15) other than the glucuronide in rats. Although these metabolites could not be identified in the present investigation, there is a possibility that there might be the metabolites corresponding to them among the spots 8, 11, 16, and 17.
It was already reported that4)oxazolam was converted to compounds of aminobenzophenone type via a compound of HEAB type and simultaneously to hydroxylated compounds including oxazepam via a compound of CND type. Thus, the biotransformation of cloxazolam seems to be very similar to that of oxazolam. However, there appear to be some differences between cloxazolam, and oxazolam in the relative amount of excretion of their metabolites in rats. Namely, in the urine and feces after administration of cloxazolam the metabolites of benzodiazepine type including COX and CND were excreted in a larger amount than that of benzophenone type including ADCB and ADCB-OH in contrast to oxazolam. The cause of this difference is not clear, but the fact that cloxazolam is chemically more stable than oxazolam in an acidic solution16) is of interest in relation to the difference in the metabolism of the two drugs.
